3-butyn-2-ol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 16239 |
| MeSH ID | M0535526 |
| Synonym |
|---|
| 1-methylpropargyl alcohol |
| 3-butyn-2-ol |
| 3-hydroxy-1-butyne |
| nsc222370 |
| 1-methyl-2-propynyl alcohol |
| methylethynylcarbinol |
| 3-butyne-2-ol |
| .alpha.-methylpropargyl alcohol |
| nsc-222370 |
| 1-butyn-3-ol |
| 65337-13-5 |
| but-3-yn-2-ol |
| dl-3-butyn-2-ol |
| 1-ethynylethanol |
| nsc 222370 |
| alpha-methylpropargyl alcohol |
| ai3-37957 |
| brn 0635722 |
| einecs 217-978-1 |
| 2028-63-9 |
| 3-butyn-2-ol, 97% |
| B0750 |
| ethynylmethylcarbinol |
| B1001 |
| FT-0655709 |
| FT-0694490 |
| A835068 |
| EN300-84568 |
| 4-01-00-02218 (beilstein handbook reference) |
| BBL013177 |
| STL163957 |
| AKOS005716681 |
| FT-0615275 |
| FT-0605323 |
| 1-butyne-3-ol |
| (+/-)-3-butyn-2-ol |
| 3-but-1-ynol |
| but-1-yn-3-ol |
| 3-butine-2-ol |
| 1-methylprop-2-ynol |
| hc.$.cch(ch3)oh |
| DTXSID3022297 |
| butyn-2-ol |
| F0001-0714 |
| methyl ethynyl carbinol |
| 2-hydroxy-3-butyne |
| 1-methyl-2-propyn-1-ol |
| 3-methyl-1-propyn-3-ol |
| mfcd00004541 |
| J-013181 |
| BCP05896 |
| BCP29700 |
| (2s)-but-3-yn-2-ol;(s)-(-)-1-butyn-3-ol |
| SB40660 |
| PB47873 |
| SY007471 |
| Z1251193370 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (41.16) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||